Answers are grounded in this paper and cite their sources.
Scoping review highlights limited use of peripheral magnetic stimulation in internal diseases, suggesting new treatment protocols.
Peripheral magnetic stimulation is primarily used to treat musculoskeletal, neurological, and incontinence-related diseases, with outcomes centered on disease-specific assessments of muscle and physical function. However, its application in internal diseases remains limited, especially in cardiovascular disease, cancer, and diabetes mellitus. In addition, standardized peripheral magnetic stimulation prescriptions have not yet been established. Future studies should emphasize its implementation in underserved diseases and dysfunctions and establish standardized treatment protocols.
No takes yet. Share an insight, caveat, or question.
Fukushima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: